.jpg)
Digital Archive
This story is part of our historical records. While preserved for reference, some details and facts may have evolved since its original publication 6 months ago.
Else Successfully Completes Second Preclinical Study on the Path For FDA Approval of World's First Whole Plant, Soy-Free Infant Formula
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant formula, which is a crucial phase for bringing the Company’s innovative 0-12 month...
S
Sangri Today Spotlight
BREAKING
Sangri Today
4 years ago
Else Successfully Completes Second Preclinical Study on the Path For FDA Approval of World's First Whole Plant, Soy-Free Infant Formula
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant formula, which is a crucial phase for bringing the Company’s innovative 0-12 month...
Full Story: https://www.sangritoday.com/spotlight/else-successfully-completes-second-preclinical-study-on-the-path-for-fda-approval-of-worlds-first-whole-plant-soy-free-infant-formula
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant formula, which is a crucial phase for bringing the Company’s innovative 0-12 month infant formula to market.
history
This is an archived post. The information provided may be outdated.
